(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid

C85H105Cl2N11O27S — CID 46902077

IUPAC(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid
SMILESCCCCCCc1ccc(S(=O)(=O)NCCCCCCNC(=O)Oc2cc(O)c3c(c2)[C@@H](C(=O)O)NC(=O)[C@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)c5ccc(c(Cl)c5)Oc5cc4cc(c5O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)Oc4ccc(cc4Cl)[C@H]2O)c2ccc(O)c-3c2)cc1
InChIInChI=1S/C85H105Cl2N11O27S/c1-7-8-9-12-15-41-16-21-47(22-17-41)126(117,118)92-27-14-11-10-13-26-91-84(116)120-46-34-49-63(55(101)35-46)48-29-42(18-23-54(48)100)64-78(110)98-68(81(113)96-66(49)82(114)115)70(104)44-20-25-57(51(87)31-44)122-59-33-45-32-58(73(59)125-83-74(72(106)71(105)60(38-99)123-83)124-62-37-85(5,89)75(107)40(4)119-62)121-56-24-19-43(30-50(56)86)69(103)67(97-76(108)52(90-6)28-39(2)3)80(112)93-53(36-61(88)102)77(109)94-65(45)79(111)95-64/h16-25,29-35,39-40,52-53,60,62,64-72,74-75,83,90,92,99-101,103-107H,7-15,26-28,36-38,89H2,1-6H3,(H2,88,102)(H,91,116)(H,93,112)(H,94,109)(H,95,111)(H,96,113)(H,97,108)(H,98,110)(H,114,115)/t40-,52+,53-,60+,62-,64+,65+,66-,67+,68-,69+,70+,71+,72-,74+,75+,83-,85-/m0/s1
InChIKeyJGVPPPJAPWINFA-GVHLGEMUSA-N
MW1815.80 g/mol
LogP4.15
Rot. Bonds28

About (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid

(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid (PubChem CID 46902077) has the molecular formula C85H105Cl2N11O27S and a molecular weight of 1815.80 g/mol. Its IUPAC name is (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid.

Molecular Properties

Compound Name(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid
PubChem CID46902077
Molecular FormulaC85H105Cl2N11O27S
Molecular Weight1815.80 g/mol
Exact Mass1813.63
IUPAC Name(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid
SMILESCCCCCCc1ccc(S(=O)(=O)NCCCCCCNC(=O)Oc2cc(O)c3c(c2)[C@@H](C(=O)O)NC(=O)[C@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)c5ccc(c(Cl)c5)Oc5cc4cc(c5O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)Oc4ccc(cc4Cl)[C@H]2O)c2ccc(O)c-3c2)cc1
InChIInChI=1S/C85H105Cl2N11O27S/c1-7-8-9-12-15-41-16-21-47(22-17-41)126(117,118)92-27-14-11-10-13-26-91-84(116)120-46-34-49-63(55(101)35-46)48-29-42(18-23-54(48)100)64-78(110)98-68(81(113)96-66(49)82(114)115)70(104)44-20-25-57(51(87)31-44)122-59-33-45-32-58(73(59)125-83-74(72(106)71(105)60(38-99)123-83)124-62-37-85(5,89)75(107)40(4)119-62)121-56-24-19-43(30-50(56)86)69(103)67(97-76(108)52(90-6)28-39(2)3)80(112)93-53(36-61(88)102)77(109)94-65(45)79(111)95-64/h16-25,29-35,39-40,52-53,60,62,64-72,74-75,83,90,92,99-101,103-107H,7-15,26-28,36-38,89H2,1-6H3,(H2,88,102)(H,91,116)(H,93,112)(H,94,109)(H,95,111)(H,96,113)(H,97,108)(H,98,110)(H,114,115)/t40-,52+,53-,60+,62-,64+,65+,66-,67+,68-,69+,70+,71+,72-,74+,75+,83-,85-/m0/s1
InChIKeyJGVPPPJAPWINFA-GVHLGEMUSA-N
XLogP4.15
TPSA594.76 Ų
H-Bond Donors20
H-Bond Acceptors28
Rotatable Bonds28
Heavy Atoms126
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001815.80
LogP ≤ 54.15
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid?
The IUPAC name of (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid (CID 46902077) is (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid.
What is the SMILES notation for (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid?
The canonical SMILES for (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid is CCCCCCc1ccc(S(=O)(=O)NCCCCCCNC(=O)Oc2cc(O)c3c(c2)[C@@H](C(=O)O)NC(=O)[C@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)c5ccc(c(Cl)c5)Oc5cc4cc(c5O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)Oc4ccc(cc4Cl)[C@H]2O)c2ccc(O)c-3c2)cc1.
What is the InChIKey of (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid?
The InChIKey is JGVPPPJAPWINFA-GVHLGEMUSA-N. The full InChI is InChI=1S/C85H105Cl2N11O27S/c1-7-8-9-12-15-41-16-21-47(22-17-41)126(117,118)92-27-14-11-10-13-26-91-84(116)120-46-34-49-63(55(101)35-46)48-29-42(18-23-54(48)100)64-78(110)98-68(81(113)96-66(49)82(114)115)70(104)44-20-25-57(51(87)31-44)122-59-33-45-32-58(73(59)125-83-74(72(106)71(105)60(38-99)123-83)124-62-37-85(5,89)75(107)40(4)119-62)121-56-24-19-43(30-50(56)86)69(103)67(97-76(108)52(90-6)28-39(2)3)80(112)93-53(36-61(88)102)77(109)94-65(45)79(111)95-64/h16-25,29-35,39-40,52-53,60,62,64-72,74-75,83,90,92,99-101,103-107H,7-15,26-28,36-38,89H2,1-6H3,(H2,88,102)(H,91,116)(H,93,112)(H,94,109)(H,95,111)(H,96,113)(H,97,108)(H,98,110)(H,114,115)/t40-,52+,53-,60+,62-,64+,65+,66-,67+,68-,69+,70+,71+,72-,74+,75+,83-,85-/m0/s1.
What are the key properties of (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid?
(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid has a molecular weight of 1815.80 g/mol, XLogP of 4.15, 28 rotatable bonds, 20 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-37-[6-[(4-hexylphenyl)sulfonylamino]hexylcarbamoyloxy]-2,18,32,35-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid is sourced from PubChem (CID 46902077), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).